KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

Aurora Cannabis (ACB) EBIT (2017 - 2025)

Aurora Cannabis has reported EBIT over the past 9 years, most recently at $14.0 million for Q4 2025.

  • Quarterly EBIT fell 46.83% to $14.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$955591.1 through Dec 2025, down 104.3% year-over-year, with the annual reading at $3.4 million for FY2025, 110.3% up from the prior year.
  • EBIT was $14.0 million for Q4 2025 at Aurora Cannabis, up from $2.9 million in the prior quarter.
  • Over five years, EBIT peaked at $26.4 million in Q4 2024 and troughed at -$112.9 million in Q1 2021.
  • The 5-year median for EBIT is -$14.8 million (2023), against an average of -$23.4 million.
  • Year-over-year, EBIT soared 304.13% in 2024 and then plummeted 898.92% in 2025.
  • A 5-year view of EBIT shows it stood at -$44.3 million in 2021, then decreased by 11.43% to -$49.3 million in 2022, then soared by 73.79% to -$12.9 million in 2023, then soared by 304.13% to $26.4 million in 2024, then plummeted by 46.83% to $14.0 million in 2025.
  • Per Business Quant, the three most recent readings for ACB's EBIT are $14.0 million (Q4 2025), $2.9 million (Q3 2025), and -$1.1 million (Q2 2025).